Why did the Stockholm market move today?
Written after the close on
Stockholm market rose, ABB led the gain. In the latest session 13 of the index's 30 companies rose, 16 fell and one was flat, with ABB climbing sharply as buybacks and news about AI data-centre demand lifted it, while AstraZeneca fell clearly and Atlas Copco rose clearly, outpacing a firmer Stockholm market. Over the past five trading days the index slipped slightly even as the broad US market was roughly flat, so the weakness was mostly local. That softness likely reflects a rotation out of defensive pharma names such as AstraZeneca, partly offset by strength in industrials tied to power and data-centre investment. Buybacks are when a company purchases its own shares, which can support the price.
Biggest risers
- Boliden +3.71%
Boliden steg kraftigt i den senaste sessionen.
- ABB +3.02%
ABB rose sharply as buybacks and AI data-centre news lifted it.
- Telia +2.05%
No explanation yet for Telia
Biggest fallers
- Saab -1.70%
Saab flat as broker upgrade offsets weak market.
- AstraZeneca -1.56%
AstraZeneca fell sharply as investors weighed fresh cancer-deal spending.
- Volvo -1.13%
Volvo fell as electric-truck order loss weighed.
Earlier days
Stockholm’s market slipped, with Atlas Copco the standout. Over the last five trading days the OMX Stockholm 30 Index fell clearly, in line with a clearly weaker S&P 500, while in the latest session it was roughly unchanged even as the S&P 500 eased slightly. In that last session 16 of its 30 companies fell, 12 rose and two were flat; Atlas Copco rose sharply as record order growth stayed in focus, ABB slipped slightly as target cuts offset data-centre news, and AstraZeneca eased as a large cancer bet met a soft market. The broader weakness likely reflects global risk appetite rather than anything Sweden-specific, since the index moved in step with the US market; a “target cut” means analysts lowered their expected share price for a company.